Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 5(128), p. 877-885, 2022
DOI: 10.1038/s41416-022-02086-w
Links
Tools
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)
Journal article published in 2022 by
Giulia Orsi,
Alessandro Cavaliere,
Giampaolo Tortora 
,
Sara Lonardi ,
Marina Macchini,
Mariacristina Di Marco,
Guido Giordano,
Enrico Vasile,
Mario Scartozzi ,
Silvia Bozzarelli,
Silvia Noventa,
Maria Grazia Rodriquenz,
Anna Maria Militello,
Ilario Giovanni Rapposelli,
Ingrid Garajova
and other authors.
,
Sara Lonardi ,
Marina Macchini,
Mariacristina Di Marco,
Guido Giordano,
Enrico Vasile,
Mario Scartozzi ,
Silvia Bozzarelli,
Silvia Noventa,
Maria Grazia Rodriquenz,
Anna Maria Militello,
Ilario Giovanni Rapposelli,
Ingrid Garajova
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 